CYH:NYE-Community Health Systems Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.32

Change

+0.23 (+5.62)%

Market Cap

USD 0.77B

Volume

1.93M

Analyst Target

USD 4.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. The company was incorporated in 1996 and is headquartered in Franklin, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+0.25 (+0.07%)

USD 105.82B
UHS Universal Health Services Inc

+1.58 (+0.77%)

USD 15.62B
THC Tenet Healthcare Corporation

-4.68 (-2.88%)

USD 15.10B
DVA DaVita HealthCare Partners Inc

-17.09 (-10.80%)

USD 13.69B
EHC Encompass Health Corp

+1.34 (+1.34%)

USD 9.63B
CHE Chemed Corp

-74.00 (-12.14%)

USD 9.04B
CON Concentra Group Holdings Paren..

+0.56 (+2.77%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.23 (-1.23%)

USD 2.59B
NHC National HealthCare Corporatio..

-3.06 (-2.51%)

USD 1.83B
AMN AMN Healthcare Services Inc

-1.10 (-2.71%)

USD 1.54B

ETFs Containing CYH

ETP:CA First Trust Global Risk M.. 3.68 % 0.98 %

N/A

CAD 0.01B
CJNK 0.00 % 0.30 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 38.02% 74% C 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.02% 74% C 88% B+
Trailing 12 Months  
Capital Gain 108.70% 83% B 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 108.70% 83% B 92% A
Trailing 5 Years  
Capital Gain 35.00% 67% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.00% 67% D+ 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 41.67% 87% B+ 92% A
Dividend Return 41.67% 87% B+ 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 121.32% 13% F 7% C-
Risk Adjusted Return 34.35% 52% F 51% F
Market Capitalization 0.77B 43% F 54% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector